Publications

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

 136
Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

Tags:

Previous Article

Interplay between mesothelial and immune cells in the tumor microenvironment

Next Article

LSD analogue with potential for treating schizophrenia

Related Posts

Rapid microbiome restructuring associated with medical exposure in remote Amazonian Indigenous communities

Rapid microbiome restructuring associated with medical ...

 44

Proximity labeling of axonemal protein CFAP91 identifies EFCAB5 that regulates sperm motility

Proximity labeling of axonemal protein CFAP91 identifie...

 84

Acute exposure to high-fat diet impairs ILC3 functions and gut homeostasis

Acute exposure to high-fat diet impairs ILC3 functions ...

 173